|
กก
Sunwin International Neutraceuticals to
Participate in Investor Conferences, Meetings
Oct 13, 2008
Sunwin International Neutraceuticals, Inc.(OTCBB: SUWN) a leader in
the production and distribution of Chinese herbs,veterinary
medicines and one of the world's leading producers of allnatural,
zero calorie Stevia in China, will participate in a number
ofupcoming investor conference and meetings.
The company will participate in or host several investor events this
fall.To participate in conference venues please contact the
conferenceorganizer. Investor meetings on company trips or around
conference venuescan be scheduled by contacting Matt Kreps on behalf
of the company at469-362-5960.
-- Management will host investor meetings in New York October
21-23.-- Sunwin will present at the Rodman & Renshaw Global
Investment Conference at the New York Palace Hotel November 10-12 as
part of the Asia & Growth Track program.-- Management
representatives will be attending the Roth Capital Partners China
Comes to Vegas Conference at the Wynn Hotel in Las Vegas November
19- 21; management will be available to meet with interested
investors.-- Management will be available to schedule
teleconferences with interested investors in additional markets
throughout the fall as well as additional planned investor venues.
President and Chairman Laiwang Zhang commented, "Sunwin has posted
stronggrowth averaging 50% as well as increasing positive cash flows
andprofitability. With the continued growth and positive outlook for
ourbusinesses both in China and the US, it is time to reach out to
the marketswith our corporate story. The company currently trades at
a discount to thevalue of its assets making this a compelling
opportunity to add value forour shareholders."
Company Background:
Sunwin International Neutraceuticals, Inc. engages in the areas
ofessential traditional Chinese medicine, zero calorie natural
sweeteners(stevia), and veterinary medicines and feeds prepared from
100 percentorganic herbal ingredients. As an industry leader in
agriculturalprocessing, Sunwin has built an integrated global firm
with the sourcingand production capabilities to meet the needs of
consumers throughout theworld. Sunwin also makes such value-added
products as specialty veterinaryfood ingredients and specialty feed
ingredients. For more info aboutSunwin, please visit
http://www.sunwininternational.com
Safe Harbor Statement
In connection with the safe harbor provisions of the Private
SecuritiesLitigation Reform Act of 1995, Sunwin International
Neutraceuticals, Inc.,is hereby providing cautionary statements
identifying important factorsthat could cause our actual results to
differ materially from thoseprojected in forward-looking statements
(as defined in such act). Anystatements that are not historical
facts and that express, or involvediscussions as to, expectations,
beliefs, plans, objectives, assumptions orfuture events or
performance (often, but not always, indicated through theuse of
words or phrases such as "will likely result," "are expected
to,""will continue," "is anticipated," "estimated," "intends,"
"plans,""believes" and "projects") may be forward-looking and may
involve estimatesand uncertainties which could cause actual results
to differ materiallyfrom those expressed in the forward-looking
statements. These statementsinclude, but are not limited to, our
guidance and expectations regardingrevenues, net income and
earnings. In addition, any such statements arequalified in their
entirety by reference to, and are accompanied by, thefollowing key
factors that have a direct bearing on our results ofoperations: our
ability to effectively integrate our acquisitions and tomanage our
growth and our inability to fully realize any anticipatedbenefits of
acquired business; our need for additional financing which wemay not
be able to obtain on acceptable terms, the dilutive effectadditional
capital raising efforts in future periods may have on ourcurrent
shareholders; our dependence on certain key personnel; the lack
ofvarious legal protections in certain agreements to which we are a
party andwhich are material to our operations which are customarily
contained insimilar contracts prepared in the United States; the
business operatingrisks and new technology in the business we seek
to enter into andcurrently operate in; the effect of changes
resulting from the politicaland economic policies of the Chinese
government on our assets andoperations located in the PRC; the
influence of the Chinese government overthe manner in which our
Chinese subsidiaries must conduct our businessactivities; the
limitation on our ability to receive and use our revenueseffectively
as a result of restrictions on currency exchange in China;
ourability to enforce our rights due to policies regarding the
regulation offoreign investments in China; our ability to comply
with the United StatesForeign Corrupt Practices Act which could
subject us to penalties and otheradverse consequences; and our
ability to establish adequate management,legal and financial
controls in the PRC.
We caution that the factors described herein could cause actual
results todiffer materially from those expressed in any
forward-looking statements wemake and that investors should not
place undue reliance on any suchforward-looking statements. Further,
any forward-looking statement speaksonly as of the date on which
such statement is made, and we undertake noobligation to update any
forward-looking statement to reflect events orcircumstances after
the date on which such statement is made or to reflectthe occurrence
of anticipated or unanticipated events or circumstances. Newfactors
emerge from time to time, and it is not possible for us to
predictall of such factors. Further, we cannot assess the impact of
each suchfactor on our results of operations or the extent to which
any factor, orcombination of factors, may cause actual results to
differ materially fromthose contained in any forward-looking
statements.
กก
กก
กก |
